Increased Serum Interleukin-17A Levels Correlate with Disease Severity and Poor Prognostic Factors in Patients with Alopecia Areata
October 2021
in “
Dermatology Reports
”
TLDR Higher IL-17A levels indicate more severe alopecia areata.
In a study involving 36 patients with alopecia areata (AA) and 20 healthy controls, researchers found that serum interleukin-17A (IL-17A) levels were significantly higher in AA patients (P=0.004). Higher IL-17A levels correlated with more severe disease, personal atopy, nail abnormalities, and active disease phases. These results suggest that IL-17A is crucial in AA pathogenesis and could serve as a valuable clinical biomarker for disease severity and activity.